doi: 10.1161/01.HYP.0000018590.26853.C7
(Hypertension. 2002;39:1101.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension
From the Division of Nephrology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, Calif.
Correspondence to Vito M. Campese, MD, Division of Nephrology, LAC/USC Medical Center, 1200 North State Street, Los Angeles, CA 90033. E-mail campese{at}hsc.usc.edu
Abstract— We have developed a new model of neurogenic hypertension in the rat, in which hypertension is caused by injecting 50 µL of 10% phenol in the lower pole of one kidney. Administration of phenol in the kidney causes an immediate and persistent rise in blood pressure (BP), norepinephrine (NE) secretion from the posterior hypothalamic nuclei (PH), and renal sympathetic nerve activity (RSNA). Because angiotensin II (Ang II) is known to stimulate central and peripheral sympathetic nervous system (SNS) activity, we have tested the hypothesis that losartan, a specific Ang II AT1 receptor antagonist, may lower BP, at least in part, by SNS inhibition. To this end, we studied the effects of losartan on BP and SNS activity following intrarenal phenol injection. Central SNS activity was measured by NE secretion from the PH using a microdialysis technique, and peripheral SNS activity was measured by direct recording of renal nerve activity. At the end of the experiments, brains were isolated and interleukin (IL)-1ß and nitric oxide synthase (NOS) mRNA gene expression was measured by RT-PCR in the PH, paraventricular nuclei (PVN), and locus ceruleus (LC). The intrarenal injection of phenol raised BP, as well as central and renal SNS activity, but reduced the abundance of IL-1ß and neuronal NOS (nNOS) mRNA in the PH, PVN, and LC. Whether injected intravenously or in the lateral ventricle, losartan caused a significant (P<0.01) and dose-dependent inhibition of the effects of phenol on BP, NE secretion from the PH, and RSNA. Losartan also caused a significant (P<0.01) and dose-dependent rise in IL-1ß and nNOS-mRNA gene expression in the PH, PVN, and LC of phenol-injected rats. In conclusion, these studies have shown that the intrarenal injection of phenol causes a rise in central and renal SNS activity and a decrease in IL-1ß and nNOS-mRNA in the PH, PVN, and LC. Losartan prevented the rise in BP and SNS activity, as well as the decrease in IL-1ß and nNOS mRNA abundance caused by phenol. These studies have demonstrated that the antihypertensive action of losartan in the phenol renal injury model is largely mediated by inhibition of central and peripheral SNS activity and suggest that activation of IL-1ß and nNOS, 2 important modulators of central SNS activity, mediates the inhibitory action of losartan on SNS activity.
Key Words: losartan • sympathetic nervous system • hypertension, renal • nitric oxide synthase • interleukins • hypothalamus
This article has been cited by other articles:
 |
|
 |
|
  S.-G. Wei, Y. Yu, Z.-H. Zhang, R. M. Weiss, and R. B. Felder Angiotensin II-Triggered p44/42 Mitogen-Activated Protein Kinase Mediates Sympathetic Excitation in Heart Failure Rats Hypertension, August 1, 2008; 52(2): 342 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Patterson, J. J. Mullins, and K. D. Mitchell Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension Am J Physiol Renal Physiol, January 1, 2008; 294(1): F205 - F211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Weiss, M. D. Y. Liu, and J. Huang Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension Exp Physiol, January 1, 2007; 92(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ye, H. Zhong, and V. M. Campese Oxidative Stress Mediates the Stimulation of Sympathetic Nerve Activity in the Phenol Renal Injury Model of Hypertension Hypertension, August 1, 2006; 48(2): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Sheriff, M. A. P. Fontes, S. Killinger, J. Horiuchi, and R. A. L. Dampney Blockade of AT1 receptors in the rostral ventrolateral medulla increases sympathetic activity under hypoxic conditions Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R733 - R740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lu, B. G. Helwig, R. J. Fels, S. Parimi, and M. J. Kenney Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2626 - H2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. D. Watson, R. Mogulkoc, R. M. McAllen, and C. N. May Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1051 - R1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Grisk and R. Rettig Interactions between the sympathetic nervous system and the kidneys in arterial hypertension Cardiovasc Res, February 1, 2004; 61(2): 238 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ito, M. Hiratsuka, K. Komatsu, K. Tsukamoto, K. Kanmatsuse, and A. F. Sved Ventrolateral Medulla AT1 Receptors Support Arterial Pressure in Dahl Salt-Sensitive Rats Hypertension, March 1, 2003; 41(3): 744 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Yang, P. K. K. Leong, S. Ye, V. M. Campese, and A. A. McDonough Responses of proximal tubule sodium transporters to acute injury-induced hypertension Am J Physiol Renal Physiol, February 1, 2003; 284(2): F313 - F322. [Abstract] [Full Text] [PDF]
|
|